Bank of New York Mellon’s Cellebrite CLBT Stock Holding History

Bank of New York Mellon’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.5M	Buy	1,744,018 +410,455	+31%	+$5.42M	﹤0.01%	1477
2026 Q1	$18.4M	Buy	1,333,563 +689,367	+107%	+$10.4M	﹤0.01%	1589
2025 Q4	$11.6M	Sell	644,196 -876,844	-58%	-$15.7M	﹤0.01%	1851
2025 Q3	$28.2M	Buy	1,521,040 +233,086	+18%	+$3.66M	0.01%	1341
2025 Q2	$20.6M	Buy	1,287,954 +133,651	+12%	+$2.38M	﹤0.01%	1501
2025 Q1	$22.4M	Buy	+1,154,303	New	+$24.3M	﹤0.01%	1434

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Central Securities New York $1.34B AUM 21.03% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Roubaix Capital Denver, Colorado $279M AUM 54.84% 1-Year Est. Return

Bank of New York Mellon's CLBT Position: Q2 2026 in Review

Bank of New York Mellon increased its Cellebrite (CLBT) stake by 31% in Q2 2026, buying an estimated $5.42M and bringing the position to 1,744,018 shares worth $25.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Bank of New York Mellon first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $28.2M in Q3 2025. 75 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Bank of New York Mellon held 1,744,018 shares of Cellebrite worth $25.5M as of Q2 2026.
Bank of New York Mellon bought 410,455 Cellebrite shares in Q2 2026, an estimated $5.42M.
Cellebrite made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1477 holding.
Bank of New York Mellon first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
Bank of New York Mellon's Cellebrite position peaked at $28.2M in Q3 2025.
75 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.